Disparities in HIV clinic care across Europe: findings from the EuroSIDA clinic survey

Abstract

BackgroundAlthough advances in HIV medicine have yielded increasingly better treatment outcomes in recent years, HIV-positive people with access to antiretroviral therapy (ART) still face complex health challenges. The EuroSIDA Study Group surveyed its clinics to explore regional differences in clinic services.MethodsThe EuroSIDA study is a prospective observational cohort study that began enrolling patients in 1994. In early 2014, we conducted a 59-item survey of the 98 then-active EuroSIDA clinics. The survey covered HIV clinical care and other aspects of patient care. The EuroSIDA East Europe study region (Belarus, Estonia, Lithuania, the Russian Federation and Ukraine) was compared to a “non-East Europe” study region comprised of all other EuroSIDA countries.ResultsA larger proportion of clinics in the East Europe group reported deferring ART in asymptomatic patients until the CD4 cell count dropped below 350 cells/mm3 (75 % versus 25 %, p = 0.0032). Considerably smaller proportions of East Europe clinics reported that resistance testing was provided before ART initiation (17 % versus 86 %, p < 0.0001) and that it was provided upon treatment failure (58 % versus 90 %, p = 0.0040). Only 33 % of East Europe clinics reported providing hepatitis B vaccination, compared to 88 % of other clinics (p < 0.0001). Only 50 % of East Europe clinics reported having access to direct-acting antivirals for hepatitis C treatment, compared to 89 % of other clinics (p = 0.0036). There was significantly less tuberculosis/HIV treatment integration in the East Europe group (27 % versus 84 % p < 0.0001) as well as significantly less screening for cardiovascular disease (58 % versus 90 %, p = 0.014); tobacco use (50 % versus 93 %, p < 0.0001); alcohol consumption (50 % versus 93 %, p < 0.0001); and drug use (58 % versus 87 %, p = 0.029).ConclusionsStudy findings demonstrate how specific features of HIV clinics differ across Europe. Significantly more East Europe clinics deferred ART in asymptomatic patients for longer, and significantly fewer East Europe clinics provided resistance testing before initiating ART or upon ART failure. The East Europe group of clinics also differed in regard to hepatitis B vaccination, direct-acting antiviral access, tuberculosis/HIV treatment integration and screening for other health issues. There is a need for further research to guide setting-specific decision-making regarding the optimal array of services at HIV clinics in Europe and worldwide.Electronic supplementary materialThe online version of this article (doi:10.1186/s12879-016-1685-x) contains supplementary material, which is available to authorized users.

New HIV diagnoses among adults aged 50 years or older in 31 European countries, 2004–15: an analysis of surveillance data

“…8,9 Only Norway and the UK had significant increases in new reported diagnoses in older people coupled with significant decreases in younger people. Although the observed differences in notification rates among older adults across the EU/EEA are probably the result of several factors that differ across the region, including risk-behaviour patterns, health-seeking behaviours, testing programmes and patterns, and levels of stigma, 5,9,16 our findings suggest a new direction or new directions in which the epidemic is evolving.…”

Adolescents with HIV and transition to adult care in the Caribbean, Central America and South America, Eastern Europe and Asia and Pacific regions

“…Linkages to other services (e.g. for TB treatment) are often weak [61]. However, progress has been made to decentralize ART provision in Ukraine in recent years [62].…”

“…ART access for children has been prioritized in EE and currently ART coverage is >90% in Ukraine and 75% in Russia [10,23,27] vs. around 50% and 34% among adults, respectively [23,64]. Access to some aspects of HIV care such as ARV resistance testing is poor or uneven [61] and young people and their families may face additional barriers including illegal charging of users fees for non-HIV-specific services [65][66][67][68] and poor access to sexual and mental health services [69,70].…”

HIV Infection in Turkey: How Close Are We to the Target?

“…Özellikle Türkiye'nin de içinde bulunduğu ve komşuluk yaptığı Orta ve Doğu Avrupa bölgesinde ART kapsayıcılığının ve viral baskılanma oranlarının beklenenin altında olması, bölgedeki ülkelerin önemli bir kısmının, özellikle de düşük gelirli olanların halen dış fonlara bağımlı olması (19), Doğu Avrupa ülkelerinde opioid yerine koyma ve şırınga değişim programlarının bulunmaması (44) ve HIV edinme riski yüksek toplumlar için hedefli test stratejilerinin bulunmaması, bu hedefe ulaşmaktan neden uzak olduğumuzu açıklayabilir.…”